
Funding doesn’t move without demonstrated maturity
Investors and EU programs need proof of TRL progression and technical validation. Without it, capital stays out of reach.

Hospitals won’t run pilots without clinical credibility
Healthcare professionals need structured validation and real-world evidence before adopting new solutions.

Adoption stalls without a clear payer strategy
In healthcare, identifying who pays (and why) is complex. Without that clarity, scaling becomes almost impossible.

Worthmed® offers a structured digital health readiness assessment to help innovators progress across technology, clinical, and market dimensions.

Without proven technical maturity, you can’t access EU or private funding, and investors won’t commit.
We structure your technical validation roadmap so you can confidently demonstrate TRL progression and funding readiness.

Without structured clinical validation, hospitals won’t run pilots, and healthcare professionals won’t trust your solution.
We define outcomes, validate workflows, and generate real-world evidence that enables pilots and supports funding.

Identifying the buyer and payer in healthcare isn’t obvious. Without a clear strategy, scaling becomes impossible.
We help you define your payer, validate demand, and build the economic case required for adoption and scale.
Over €1.4 billion is available in 2026 through the EIC Pathfinder, Transition, and Accelerator programmes for innovators who can demonstrate where their technology stands today and where it is headed.

See how Worthmed® is helping transform digital health innovation.
“Worthmed is a great advantage for innovators, as it allows us to show stakeholders how we intend to carry out the scientific validation of our solutions.”

“Worthmed helped us identify which parts of our project to focus on and which needed further evaluation and development, saving us time and resources.”
